Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Turn Biotechnologies Inc. has 1 pending office action in Biotechnology & Pharmaceuticals. The matter is assigned to 1 examiner and 1 art unit, creating a focused prosecution profile.
TRAN, SUSAN T is the identified examiner and has 1 pending matter. Counsel can direct preparation toward that examiner's treatment of the application and the relevant technical group.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TRAN, SUSAN T | 1 | 63.0% | +34.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18856868 | METHODS AND COMPOSITIONS FOR IMMUNE CELL REJUVENATION AND THERAPIES USING REJUVENATED IMMUNE CELLS | TRAN, SUSAN T | — |
| Art Unit | Apps |
|---|---|
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18856868 | METHODS AND COMPOSITIONS FOR IMMUNE CELL REJUVENATION AND THERAPIES USING REJUVENATED IMMUNE CELLS | TRAN, SUSAN T | 1615 | §102 | Non-Final OA | — | Pending | Oct 14, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTurn Biotechnologies Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Susan T Tran has the most, with 1 of Turn Biotechnologies Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
